Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid
<p>Abstract</p> <p>Background</p> <p>To assess prognostic and predictive effects of clinical and biochemical factors in our published randomized study of a weekly low dose (metronomic arm) versus a conventional dosage of zoledronic acid (conventional arm) in breast canc...
Main Authors: | Wang Zhonghua, Wang Biyun, Zhang Jian, Sun Si, Jia Zhen, Zhang Qunling, Xu Xiaofeng, Zhao Xinmin, Hu Xichun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/11/403 |
Similar Items
-
Dosing of zoledronic acid with its anti-tumor effects in breast cancer
by: Xinmin Zhao, et al.
Published: (2015-09-01) -
EFFICACY OF ZOLEDRONIC ACID IN THE PREVENTION OF BONE METASTASES IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
by: T. N. Musaev, et al.
Published: (2014-07-01) -
EFFICACY OF ZOLEDRONIC ACID IN THE PREVENTION OF BONE METASTASES IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
by: T. N. Musaev, et al.
Published: (2014-07-01) -
OUR EXPERIENCE WITH ZOLEDRONIC ACID IN THE TREATMENT OF PATIENTS WITH NON- SMALL CELL LUNG CANCER AND BONE METASTASES
by: Deyan N. Davidov
Published: (2013-04-01) -
USE OF ZOLEDRONIC ACID AND A RАNK LIGAND INHIBITOR IN THE PALLIATIVE TREATMENT OF CANCERS OF THE PROSTATE WITH BONE METASTASES
by: S. V. Mushigin, et al.
Published: (2014-07-01)